Anti-Pertussis toxin antibody
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Polyclonal TOX1 antibody. Suitable for ELISA, WB and reacts with Bordetella pertussis samples. Cited in 1 publication. Immunogen corresponding to Recombinant Full Length Protein corresponding to Bordetella pertussis Tohama I ptxA.
View Alternative Names
BP3783, ptxA, Pertussis toxin subunit 1, PTX S1, Islet-activating protein S1, NAD-dependent ADP-ribosyltransferase, IAP S1
- WB
Supplier Data
Western blot - Anti-Pertussis toxin antibody (AB193494)
All lanes:
Western blot - Anti-Pertussis toxin antibody (ab193494) at 2 µg/mL
All lanes:
Recombinant Bordella pertussis pertussis toxin subunit 1 at 0.1 µg
Secondary
All lanes:
Polyclonal goat anti-rabbit IgG at 1/1000 dilution
Predicted band size: 30 kDa
Observed band size: 36 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This toxin disrupts immune surveillance and modulates host immune responses to facilitate infection by Bordetella pertussis. Pertussis toxin is not an isolated agent but functions in concert with other virulence factors produced by the bacterium. This synergy potentiates its ability to impair neutrophil recruitment and function. Moreover PT impacts the ciliary activity in the respiratory tract contributing to the characteristic coughing in whooping cough by limiting the clearance of respiratory secretions.
Pathways
ADP-ribosylation by pertussis toxin directly affects the inhibitory G-proteins specifically Giα which play important roles in several signaling pathways including the cAMP signaling pathway. The toxin's ability to increase the levels of cAMP disrupts normal intracellular signaling leading to altered leukocyte behavior. Such disruptions extend its influence into pathways involving proteins such as adenylyl cyclase and phospholipase C which further modulate immune responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Additional targets
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
International journal of molecular medicine 41:3327-3341 PubMed29512687
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com